Pharmaceutical combination
USRE39264E1 · kind E1 · reissue
8Cited by
10References
27Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Feb 2, 1996 |
| Grant date | Sep 5, 2006 |
| Priority date | — |
| Expiry date | Feb 2, 2016 |
Classification
- Technology area (CPC —)General
Abstract
The invention relates to pharmaceutical compositions for topical administration comprising a topically acceptable antiviral substance and an antiinflammatory glucocorticoid in a pharmaceutically acceptable carrier. The pharmaceutical composition can be used in the prophylactic and curative treatment of herpesvirus infections in mammals including man. The invention also relates to the use of a combination of a topically acceptable antiviral substance and an antiinflammatory glucocorticoid for the manufacture of a medicament for said prophylactic and curative treatment.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.